Single-dose intraoperative radiotherapy during lumpectomy for breast cancer: an innovative patient-centred treatment.
Journal
British journal of cancer
ISSN: 1532-1827
Titre abrégé: Br J Cancer
Pays: England
ID NLM: 0370635
Informations de publication
Date de publication:
04 2021
04 2021
Historique:
received:
09
10
2020
accepted:
11
12
2020
revised:
04
12
2020
pubmed:
4
2
2021
medline:
28
9
2021
entrez:
3
2
2021
Statut:
ppublish
Résumé
In the randomised TARGIT-A trial, risk-adapted targeted intraoperative radiotherapy (TARGIT-IORT) during lumpectomy was non-inferior to whole-breast external beam radiotherapy, for local recurrence. In the long-term, no difference was found in any breast cancer outcome, whereas there were fewer deaths from non-breast-cancer causes. TARGIT-IORT should be included in pre-operative consultations with eligible patients.
Identifiants
pubmed: 33531693
doi: 10.1038/s41416-020-01233-5
pii: 10.1038/s41416-020-01233-5
pmc: PMC7851812
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Comment
Langues
eng
Sous-ensembles de citation
IM
Pagination
1469-1474Subventions
Organisme : Department of Health
ID : 14/49/13
Pays : United Kingdom
Organisme : Department of Health
ID : 07/60/49
Pays : United Kingdom
Organisme : Department of Health
ID : 10/104/07
Pays : United Kingdom
Investigateurs
Frederik Wenz
(F)
Samuele Massarut
(S)
Steffi Pigorsch
(S)
Michael Alvarado
(M)
Michael Douek
(M)
Christobel Saunders
(C)
Henrik L Flyger
(HL)
Wolfgang Eiermann
(W)
Chris Brew-Graves
(C)
Norman R Williams
(NR)
Ingrid Potyka
(I)
Nicholas Roberts
(N)
Marcelle Bernstein
(M)
Douglas Brown
(D)
Elena Sperk
(E)
Siobhan Laws
(S)
Marc Sütterlin
(M)
Tammy Corica
(T)
Steinar Lundgren
(S)
Dennis Holmes
(D)
Lorenzo Vinante
(L)
Fernando Bozza
(F)
Montserrat Pazos
(M)
Magali Le Blanc-Onfroy
(M)
Günther Gruber
(G)
Wojciech Polkowski
(W)
Konstantin J Dedes
(KJ)
Marcus Niewald
(M)
Jens Blohmer
(J)
David McCready
(D)
Richard Hoefer
(R)
Pond Kelemen
(P)
Gloria Petralia
(G)
Mary Falzon
(M)
David J Joseph
(DJ)
Commentaires et corrections
Type : CommentOn
Références
Vaidya, J. S., Vyas, J. J., Chinoy, R. F., Merchant, N., Sharma, O. P. & Mittra, I. Multicentricity of breast cancer: whole-organ analysis and clinical implications. Br. J. Cancer 74, 820–824 (1996).
pubmed: 8795588
pmcid: 2074702
Vaidya, J. S., Wenz, F., Bulsara, M., Tobias, J. S., Joseph, D., Saunders, C. et al. An international randomised controlled trial to compare targeted intra-operative radiotherapy (TARGIT) with conventional post-operative radiotherapy after conservative breast surgery for women with early stage breast cancer (The TARGIT-A trial). Health Technol. Assess. 20, 1–226 (2016).
pubmed: 27689969
pmcid: 5056335
Vaidya, J. S., Bulsara, M., Baum, M., Wenz, F., Massarut, S., Pigorsch, S. et al. Long term survival and local control outcomes from single dose targeted intraoperative radiotherapy during lumpectomy (TARGIT-IORT) for early breast cancer: TARGIT-A randomised clinical trial. BMJ 370, m2836 (2020).
pubmed: 32816842
pmcid: 7500441
Veronesi, U., Orecchia, R., Maisonneuve, P., Viale, G., Rotmensz, N., Sangalli, C. et al. Intraoperative radiotherapy versus external radiotherapy for early breast cancer (ELIOT): a randomised controlled equivalence trial. The Lancet Oncology 14, 1269–1277 (2013).
pubmed: 24225155
Vaidya, J. S., Bulsara, M., Saunders, C., Flyger, H., Tobias, J. S., Corica, T. et al. Effect of delayed targeted intraoperative radiotherapy vs whole-breast radiotherapy on local recurrence and survival. JAMA Oncology 6, e200249 (2020).
pubmed: 32239210
pmcid: 7348682
Strnad, V., Ott, O. J., Hildebrandt, G., Kauer-Dorner, D., Knauerhase, H., Major, T. et al. 5-year results of accelerated partial breast irradiation using sole interstitial multicatheter brachytherapy versus whole-breast irradiation with boost after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: a randomised, phase 3, non-inferiority trial. The Lancet 387, 229–238 (2016).
Vicini, F. A., Cecchini, R. S., White, J. R., Arthur, D. W., Julian, T. B., Rabinovitch, R. A. et al. Long-term primary results of accelerated partial breast irradiation after breast-conserving surgery for early-stage breast cancer: a randomised, phase 3, equivalence trial. The Lancet 394, 2155–2164 (2019).
Whelan, T. J., Julian, J. A., Berrang, T. S., Kim, D.-H., Germain, I., Nichol, A. M. et al. External beam accelerated partial breast irradiation versus whole breast irradiation after breast conserving surgery in women with ductal carcinoma in situ and node-negative breast cancer (RAPID): a randomised controlled trial. The Lancet 394, 2165–2172 (2019).
Meattini, I., Marrazzo, L., Saieva, C., Desideri, I., Scotti, V., Simontacchi, G. et al. Accelerated partial-breast irradiation compared with whole-breast irradiation for early breast cancer: long-term results of the randomized Phase III APBI-IMRT-Florence trial. J. Clin. Oncol. 38, 4175–4183 (2020).
pubmed: 32840419
Coles, C. E., Griffin, C. L., Kirby, A. M., Titley, J., Agrawal, R. K., Alhasso, A. et al. Partial-breast radiotherapy after breast conservation surgery for patients with early breast cancer (UK IMPORT LOW trial): 5-year results from a multicentre, randomised, controlled, phase 3, non-inferiority trial. The Lancet 390, 1048–1060 (2017).
Vaidya, J. S., Bulsara, M. & Baum, M. Targeted intraoperative radiotherapy for early breast cancer—reply. JAMA Oncology 6, 1637 (2020).
pubmed: 32789486
Brunt, A. M., Haviland, J. S., Wheatley, D. A., Sydenham, M. A., Alhasso, A., Bloomfield, D. J. et al. Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial. The Lancet 395, 1613–1626 (2020).
Hughes, K. S., Schnaper, L. A., Berry, D., Cirrincione, C., McCormick, B., Shank, B. et al. Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer. N. Engl. J. Med. 351, 971–977 (2004).
pubmed: 15342805
Hughes, K. S., Schnaper, L. A., Bellon, J. R., Cirrincione, C. T., Berry, D., McCormick, B. et al. Lumpectomy plus tamoxifen with or without irradiation in women age 70 years or older with early breast cancer: long-term follow-up of CALGB 9343. J. Clin. Oncol. 31, 2382–2387 (2013).
pubmed: 23690420
pmcid: 3691356
Kunkler, I. H., Williams, L. J., Jack, W. J., Cameron, D. A. & Dixon, J. M., investigators, P. I. Breast-conserving surgery with or without irradiation in women aged 65 years or older with early breast cancer (PRIME II): a randomised controlled trial. Lancet Oncol. 16, 266–273 (2015) and updated at San Antonio Breast Cancer Symposium, Dec 2020.
pubmed: 25637340
Blamey, R. W., Bates, T., Chetty, U., Duffy, S. W., Ellis, I. O., George, D. et al. Radiotherapy or tamoxifen after conserving surgery for breast cancers of excellent prognosis: British Association of Surgical Oncology (BASO) II trial. Eur. J. Cancer 49, 2294–2302 (2013).
pubmed: 23523089
Coombs, N. J., Coombs, J. M., Vaidya, U. J., Singer, J., Bulsara, M., Tobias, J. S. et al. Environmental and social benefits of the targeted intraoperative radiotherapy for breast cancer: data from UK TARGIT-A trial centres and two UK NHS hospitals offering TARGIT IORT. BMJ Open 6, e010703 (2016).
pubmed: 27160842
pmcid: 4890331
Sperk, E., Welzel, G., Keller, A., Kraus-Tiefenbacher, U., Gerhardt, A., Sutterlin, M. et al. Late radiation toxicity after intraoperative radiotherapy (IORT) for breast cancer: results from the randomized phase III trial TARGIT A. Breast Cancer Res. Treat. 135, 253–260 (2012).
pubmed: 22842984
Welzel, G., Boch, A., Sperk, E., Hofmann, F., Kraus-Tiefenbacher, U., Gerhardt, A. et al. Radiation-related quality of life parameters after targeted intraoperative radiotherapy versus whole breast radiotherapy in patients with breast cancer: results from the randomized phase III trial TARGIT-A. Radiat. Oncol. 8, 9 (2013).
pubmed: 23294485
pmcid: 3896671
Andersen, K. G., Gartner, R., Kroman, N., Flyger, H. & Kehlet, H. Persistent pain after targeted intraoperative radiotherapy (TARGIT) or external breast radiotherapy for breast cancer: a randomized trial. Breast 21, 46–49 (2012).
pubmed: 21865044
Keshtgar, M. R., Williams, N. R., Bulsara, M., Saunders, C., Flyger, H., Cardoso, J. S. et al. Objective assessment of cosmetic outcome after targeted intraoperative radiotherapy in breast cancer: results from a randomised controlled trial. Breast Cancer Res. Treat. 140, 519–525 (2013).
pubmed: 23877341
Corica, T., Nowak, A. K., Saunders, C. M., Bulsara, M., Taylor, M., Vaidya, J. S. et al. Cosmesis and breast-related quality of life outcomes after intraoperative radiation therapy for early breast cancer: a substudy of the TARGIT-A trial. Int. J. Radiat. Oncol. Biol. Phys. 96, 55–64 (2016).
pubmed: 27511847
Corica, T., Nowak, A. K., Saunders, C. M., Bulsara, M. K., Taylor, M., Williams, N. R. et al. Cosmetic outcome as rated by patients, doctors, nurses and BCCT.core software assessed over 5 years in a subset of patients in the TARGIT-A trial. Radiat. Oncol. 13, 68 (2018).
pubmed: 29653541
pmcid: 5899392
Vicini, F. A., Cecchini, R. S., White, J. R., Arthur, D. W., Julian, T. B., Rabinovitch, R. A. et al. Long-term primary results of accelerated partial breast irradiation after breast-conserving surgery for early-stage breast cancer: a randomised, phase 3, equivalence trial. Lancet 394, 2155–2164 (2019).
pubmed: 31813636
pmcid: 7199428
Gourgou-Bourgade, S., Cameron, D., Poortmans, P., Asselain, B., Azria, D., Cardoso, F. et al. Guidelines for time-to-event end point definitions in breast cancer trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)dagger. Ann. Oncol. 26, 873–879 (2015).
pubmed: 25725046
Hudis, C. A., Barlow, W. E., Costantino, J. P., Gray, R. J., Pritchard, K. I., Chapman, J. A. et al. Proposal for standardized definitions for efficacy end points in adjuvant breast cancer trials: the STEEP system. J. Clin. Oncol. 25, 2127–2132 (2007).
pubmed: 17513820
Van Gaal, L. F., Mertens, I. L. & De Block, C. E. Mechanisms linking obesity with cardiovascular disease. Nature 444, 875–880 (2006).
pubmed: 17167476
Keum, N., Greenwood, D. C., Lee, D. H., Kim, R., Aune, D., Ju, W. et al. Adult weight gain and adiposity-related cancers: a dose-response meta-analysis of prospective observational studies. J. Natl Cancer Inst. 107, djv088 (2015).
pubmed: 25757865
Vaidya, J. S., Bulsara, M., Wenz, F., Coombs, N., Singer, J., Ebbs, S. et al. Reduced mortality with partial-breast irradiation for early breast cancer: a meta-analysis of randomized trials. Int. J. Radiat. Oncol. Biol. Phys. 96, 259–265 (2016).
pubmed: 27478165
Vaidya, J. S., Bulsara, M., Wenz, F., Tobias, J. S., Joseph, D. & Baum, M. Targeted radiotherapy for early breast cancer. Lancet 391, 26–27 (2018).
pubmed: 29323648
Taylor, C., Correa, C., Duane, F. K., Aznar, M. C., Anderson, S. J., Bergh, J. et al. Estimating the risks of breast cancer radiotherapy: evidence from modern radiation doses to the lungs and heart and from previous randomized trials. J. Clin. Oncol. 35, 1641–1649 (2017).
pubmed: 28319436
pmcid: 5548226
Darby, S. C., Ewertz, M., McGale, P., Bennet, A. M., Blom-Goldman, U., Brønnum, D. et al. Risk of ischemic heart disease in women after radiotherapy for breast cancer. N. Engl. J. Med. 368, 987–998 (2013).
pubmed: 23484825
Burt, L. M., Ying, J., Poppe, M. M., Suneja, G. & Gaffney, D. K. Risk of secondary malignancies after radiation therapy for breast cancer: comprehensive results. Breast 35, 122–129 (2017).
pubmed: 28719811
Grantzau, T. & Overgaard, J. Risk of second non-breast cancer after radiotherapy for breast cancer: a systematic review and meta-analysis of 762,468 patients. Radiother. Oncol. 114, 56–65 (2015).
pubmed: 25454172
Bansod, S. & Desai, R. Nationwide prevalence and trends of acute cardiovascular and cerebrovascular events among adult breast cancer survivors with a history of radiation therapy. Breast Cancer Res. Treat. 180, 267–268 (2020).
pubmed: 31970559
Early Breast Cancer Trialists’ Collaborative, G. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 366, 2087–2106 (2005).
Marmot, M., Altman, D. G., Cameron, D. A., Dewar, J. A., Thompson, S. G. & Wilcox, M. Independent UK panel on breast cancer screening replies to Michael Baum. BMJ 346, f873 (2013).
pubmed: 23407732
Dodwell, D. J., Dyker, K., Brown, J., Hawkins, K., Cohen, D., Stead, M. et al. A randomised study of whole-breast vs tumour-bed irradiation after local excision and axillary dissection for early breast cancer. Clin. Oncol. 17, 618–622 (2005).
Ribeiro, G. G., Magee, B., Swindell, R., Harris, M. & Banerjee, S. S. The Christie Hospital breast conservation trial: an update at 8 years from inception. Clin. Oncol. 5, 278–283 (1993).
Polgar, C., Fodor, J., Major, T., Sulyok, Z. & Kasler, M. Breast-conserving therapy with partial or whole breast irradiation: ten-year results of the Budapest randomized trial. Radiother. Oncol. 108, 197–202 (2013).
pubmed: 23742961
Yadav, B. S., Loganathan, S., Sharma, S. C., Singh, R. & Dahiya, D. Comparison of toxicity and cosmetic outcomes after accelerated partial breast irradiation or whole breast irradiation using 3-dimensional conformal external beam radiation therapy. Adv. Radiat. Oncol. 5, 171–179 (2020).
pubmed: 32280816